Abstract: The invention relates to heterocyclic sulfonamide derivatives and their use in the treatment and prophylaxis of autoimmune, inflammatory, cardiovascular, neuronal, auditory, renal and metabolic mediated diseases, and to compositions containing said derivatives and processes for their preparation.
Type:
Application
Filed:
July 5, 2019
Publication date:
September 9, 2021
Applicant:
METRION BIOSCIENCES LIMITED
Inventors:
Marc ROGERS, Robert KIRBY, Gakujun SHOMI, Takuya MATSUO, Satoru KOBAYASHI, Junichiro KANAZAWA, Nobutaka YAMAOKA, Makoto TORIZUKA, Koichi SUZAWA